Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
23 studies found for:    USPIO
Show Display Options
Rank Status Study
1 Terminated
Has Results
Imaging of Intravenous (IV) Combidex to Brain, Intra-cerebral Tumors and in Central Nervous System (CNS) Inflammation
Condition: Brain Neoplasms
Interventions: Drug: Ferumoxtran-10 (Combidex);   Procedure: Neurosurgery
2 Completed USPIO-enhanced and Diffusion-weighted MRI for the Detection of Pelvic Lymph Node Metastases
Conditions: Prostate Cancer;   Bladder Cancer
Interventions: Other: Imaging: diffusion-weighted MRI;   Other: Sinerem (USPIO) enhanced MRI
3 Active, not recruiting Fludeoxyglucose F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Therapy in Finding Lymph Node Metastasis in Patients With Locally Advanced Cervical Cancer or High-Risk Endometrial Cancer
Conditions: Cervical Adenocarcinoma;   Cervical Adenosquamous Cell Carcinoma;   Cervical Small Cell Carcinoma;   Cervical Squamous Cell Carcinoma;   Endometrial Clear Cell Carcinoma;   Endometrial Papillary Serous Carcinoma;   Stage I Endometrial Carcinoma;   Stage IB Cervical Cancer;   Stage II Endometrial Carcinoma;   Stage IIA Cervical Cancer;   Stage IIB Cervical Cancer;   Stage III Cervical Cancer;   Stage III Endometrial Carcinoma;   Stage IVA Cervical Cancer
Interventions: Radiation: fludeoxyglucose F 18;   Procedure: positron emission tomography;   Procedure: computed tomography;   Drug: ferumoxtran-10;   Procedure: magnetic resonance imaging;   Procedure: diagnostic lymphadenectomy;   Procedure: lymph node biopsy
4 Unknown  The Inflammatory Process and the Medical Imaging in Patients With an Inflammatory Disease of the Central Nervous System.
Conditions: Multiple Sclerosis (MS);   Inflammatory Disease
Intervention: Other: USPIO MRI  -  Gadolinium MRI
5 Completed Combidex USPIO - Ultra-Small Superparamagnetic Iron Oxide
Conditions: Uterine Neoplasms;   Cervix Neoplasms;   Bladder Neoplasms;   Prostatic Neoplasms
Intervention: Procedure: MRI contrast agent Combidex (ferumoxtran-10)
6 Completed Magnetic Resonance Imaging Using Ferumoxtran-10 in Finding Metastases to the Axillary Lymph Nodes in Patients With Breast Cancer
Condition: Breast Cancer
Interventions: Drug: ferumoxtran-10;   Procedure: magnetic resonance imaging;   Procedure: sentinel lymph node biopsy
7 Completed Effects Of Atorvastatin On Macrophage Activity And Plaque Inflammation Using Magnetic Resonance Imaging
Conditions: Atherosclerotic Carotid Disease;   Atheroma
Intervention: Drug: atorvastatin
8 Terminated
Has Results
A Validation Study of MR Lymphangiography Using SPIO, a New Lymphotropic Superparamagnetic Nanoparticle Contrast
Conditions: Bladder Cancer;   Genitourinary Cancer;   Prostate Cancer
Interventions: Drug: Ferumoxtran-10 (USPIO);   Procedure: MR lymphangiography
9 Recruiting Metabolic Imaging in Carotid Atherosclerosis
Conditions: Atherosclerosis;   Stroke
Interventions: Other: USPIO (ferumoxytol)-enhanced MRI scan;   Radiation: 18f-Fluoride PET/CT scan;   Radiation: 18F-Flurodeoxyglucose PET/CT scan
10 Recruiting Innovative MRI Techniques to Improve Treatment Stratification of Patients With Esophageal Cancer
Condition: Esophageal Neoplasms
Intervention: Drug: Ferumoxytol
11 Recruiting Pre-Operative Nodal Staging of Thyroid Cancer Using Ultra-Small Superparamagnetic Iron Oxide Magnetic Resonance Imaging (USPIO MRI): Preliminary Study
Conditions: Papillary Carcinoma of Thyroid Metastatic to Regional Lymph Node;   Metastatic Medullary Thyroid Cancer;   Follicular Thyroid Cancer Lymph Node Metastasis
Interventions: Drug: Ferumoxytol;   Device: lymphotrophic superparamagnetic nanoparticles (LSN MRI).
12 Recruiting USPIO Magnetic Resonance Imaging (MRI)
Condition: Cancer of Lymph Node
Interventions: Drug: Feraheme;   Procedure: Magnetic Resonance Imaging (MRI)
13 Unknown  MR-Lymphography and Lymph Node Staging in Prostate Cancer
Conditions: Prostatic Neoplasms;   Lymphatic Metastasis
Intervention: Procedure: Ferumoxtran-10 enhanced MRI (MRL)
14 Terminated Magnetic Resonance Imaging To Predict Outcomes In Aortic Aneurysms
Condition: Abdominal Aortic Aneurysm
15 Recruiting IRon Nanoparticle Enhanced MRI in the Assessment of Myocardial infarctioN
Conditions: Myocardial Infarction;   Inflammation
Intervention: Device: Ferumoxytol enhanced MRI
16 Unknown  Magnetic Resonance Imaging of Aortic Aneurysm Instability
Condition: Aortic Aneurysm
Intervention: Drug: Sinerem administration
17 Active, not recruiting Pre-Operative Staging of Pancreatic Cancer Using Superparamagnetic Iron Oxide Magnetic Resonance Imaging (SPIO MRI)
Condition: Pancreatic Cancer
Intervention: Drug: Superparamagnetic Iron Oxide Magnetic Resonance Imaging
18 Recruiting High-Field MRI Iron-Based Contrast-Enhanced Characterization of Multiple Sclerosis and Demyelinating Diseases
Condition: Multiple Sclerosis
Interventions: Drug: Feraheme;   Drug: Gadolinium-based contrast
19 Completed A Study of Two Methodologies for Measuring Blood Flow in the Brain in Response to Non-Drug Stimuli (P08085/MK-0000-180)
Condition: Functional Magnetic Resonance Imaging
Intervention: Procedure: fMRI with sensory stimulation
20 Recruiting Ferumoxytol - Iron Oxide Nanoparticle Magnetic Resonance Dynamic Contrast Enhanced MRI
Condition: Head and Neck Cancer
Interventions: Procedure: Magnetic Resonance Imaging (MRI);   Drug: Ferumoxytol

   Previous Page Studies Shown (1-20) Next Page (21-23) Show next page of results    Last Page
Indicates status has not been verified in more than two years